Interpace Biosciences Inc
OTC:IDXG
Interpace Biosciences Inc
Net Income
Interpace Biosciences Inc
Net Income Peer Comparison
Competitive Net Income Analysis
Latest Figures & CAGR of Competitors
Company | Net Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Interpace Biosciences Inc
OTC:IDXG
|
Net Income
$920k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
DaVita Inc
NYSE:DVA
|
Net Income
$1.1B
|
CAGR 3-Years
3%
|
CAGR 5-Years
30%
|
CAGR 10-Years
2%
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Net Income
$899m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
3%
|
CAGR 10-Years
1%
|
|
CVS Health Corp
NYSE:CVS
|
Net Income
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Cigna Corp
NYSE:CI
|
Net Income
$3.9B
|
CAGR 3-Years
-23%
|
CAGR 5-Years
4%
|
CAGR 10-Years
7%
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Net Income
$434.2m
|
CAGR 3-Years
-45%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-2%
|
See Also
What is Interpace Biosciences Inc's Net Income?
Net Income
920k
USD
Based on the financial report for Mar 31, 2024, Interpace Biosciences Inc's Net Income amounts to 920k USD.